£7.0M
The investment round was led by Praetura Capital with backing from Boundary Capital Partners and other investors.
Inotec AMD develops medical technology designed to heal complex chronic wounds.
Inotec AMD develops medical technology for wound therapy, offering a device that generates pure humidified oxygen to treat complex chronic wounds. The business supplies healthcare providers and the NHS across multiple international markets.

Craig Kennedy
CEO
Craig brings extensive leadership experience in the medical and wound management sector, having previously served as chief executive officer at Inotec AMD and MolecuLight. He currently acts as vice president of commercial americas at Mölnlycke Health Care.
LinkedInAdrian Patron
Chairman
The investment round was led by Praetura Capital with backing from Boundary Capital Partners and other investors.